PATH-07. QUALITY ASSURANCE IN CEREBROSPINAL FLUID CYTOLOGY ASSESSMENT FOR MEDULLOBLASTOMA STAGING LEADS TO POTENTIAL IMPROVED RISK-GROUP ASSESSMENT IN THE PROSPECTIVE MULTICENTER HIT-2000 TRIAL

BACKGROUND: Cerebrospinal fluid (CSF) dissemination of medulloblastoma (M1 stage) is a high-risk prognostic factor. However, because diagnostic criteria for M1 staging are missing we specified process-related and cytomorphological parameters influencing the predictive value of the CSF status. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagel, Christian, Sloman, Veronika, Mynarek, Martin, Petrasch, Katharina, Obrecht, Denise, Deinlein, Frank, Schmid, Renate, von Bueren, André O, Friedrich, Carsten, Juhnke, B Ole, Gerber, Nicolas U, Kwiecien, Robert, Girschick, Hermann, Höller, Alexandra, Zapf, Antonia, von Hoff, Katja, Rutkowski, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Pathology and Molecular Diagnosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715284/
http://dx.doi.org/10.1093/neuonc/noaa222.643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715284/
http://dx.doi.org/10.1093/neuonc/noaa222.643

Ejemplares similares